Legal Representation
Attorney
Emilia F. Cannella
USPTO Deadlines
Next Deadline
77 days remaining
NOA E-Mailed - SOU Required
Due Date
March 18, 2026
Extension Available
Until September 18, 2026
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 18, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 18, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 18, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 31, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jan 31, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Nov 3, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 3, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 3, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 14, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 30, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Downloadable scientific and medical data via the internet; downloadable pathology data for use in medical and scientific research
Class 042
Analyzing and compiling pathology data; analyzing and compiling data for research purposes in the fields of pathology, medical science, and pharmaceutical consultancy; analyzing and compiling data for medical and scientific research and analytical purposes in the fields of pathology, medical science, and pharmaceutical consultancy; providing medical and scientific data analytics analysis and providing a website featuring non-downloadable software using artificial intelligence for analyzing medical and scientific data in the pathology field for the purpose of research and development; providing an internet website portal featuring medical and scientific research information and downloadable data in the fields of pathology, medical science, and pharmaceutical consultancy
Class 044
Providing medical information to oncology drug developers in the form of reports in the field of pathology; providing medical information to oncology drug developers in the form of reports in the field of pathology, medical science, and pharmaceutical consultancy
Additional Information
Pseudo Mark
PATH EXPLORE
Classification
International Classes
009
042
044